IL-5 Inhibition as a Therapy for Allergic Disease
- 30 April 1999
- journal article
- review article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 12 (2) , 81-85
- https://doi.org/10.1006/pupt.1999.0192
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- IL-5-Deficient Mice Have a Developmental Defect in CD5+ B-1 Cells and Lack Eosinophilia but Have Normal Antibody and Cytotoxic T Cell ResponsesPublished by Elsevier ,1996
- Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.The Journal of Experimental Medicine, 1996
- Evaluation of Airway Hyperreactivity in lnterleukin-5 Transgenic MiceInternational Archives of Allergy and Immunology, 1995
- Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion.The Journal of Experimental Medicine, 1994
- Characterization of a Murine Model of Allergic Pulmonary InflammationInternational Archives of Allergy and Immunology, 1994
- T cells and eosinophils in the pathogenesis of asthmaImmunology Today, 1992
- AsthmaNew England Journal of Medicine, 1992
- Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.Journal of Clinical Investigation, 1991
- Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production.The Journal of Experimental Medicine, 1991
- Eosinophilia in transgenic mice expressing interleukin 5.The Journal of Experimental Medicine, 1990